[1] ECKBURG P B, BIK E M, BERNSTEIN C N, et al.Diversity of the human intestinal microbial flora[J].Science, 2005, 308(5728):1635-1638.
[2] FURCI F, CAMINATI M, CRISAFULLI E, et al.The intriguing possibility of using probiotics in allergen-specific immunotherapy[J].World Allergy Organization Journal, 2023, 16(2):100751.
[3] HANEISHI Y, FURUYA Y, HASEGAWA M, et al.Inflammatory bowel diseases and gut microbiota[J].International Journal of Molecular Sciences, 2023, 24(4):3817.
[4] QI Y, WANG X F.The role of gut microbiota in high-fat-diet-induced diabetes:Lessons from animal models and humans[J].Nutrients, 2023, 15(4):922.
[5] KAMADA N, CHEN G Y, INOHARA N, et al. Control of pathogens and pathobionts by the gut microbiota[J].Nature Immunology, 2013, 14:685-690.
[6] PIEWNGAM P, ZHENG Y, NGUYEN T H, et al.Pathogen elimination by probiotic Bacillus via signalling interference[J].Nature, 2018, 562:532-537.
[7] GIBSON G R, HUTKINS R, SANDERS M E, et al.Expert consensus document:The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics[J].Nature Reviews Gastroenterology and Hepatology, 2017, 14(8):491-502.
[8] ROBERFROID M, GIBSON G R, HOYLES L, et al.Prebiotic effects:Metabolic and health benefits[J].The British Journal of Nutrition, 2010, 104(Suppl 2):1-63.
[9] GARRIDO D, RUIZ-MOYANO S, LEMAY D G, et al.Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria[J].Scientific Reports, 2015, 5:13517.
[10] OOZEER R, VAN LIMPT K, LUDWIG T, et al. Intestinal microbiology in early life: Specific prebiotics can have similar functionalities as human-milk oligosaccharides1[J]. The American Journal of Clinical Nutrition, 2013, 98(2):561S-571S.
[11] RUIZ-PALACIOS G M, CERVANTES L E, RAMOS P, et al.Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection[J].The Journal of Biological Chemistry, 2003, 278(16):14112-14120.
[12] YU Z T, NANTHAKUMAR N N, NEWBURG D S.The human milk oligosaccharide 2′-fucosyllactose quenches Campylobacter jejuni-induced inflammation in human epithelial cells HEp-2 and HT-29 and in mouse intestinal Mucosa1[J].The Journal of Nutrition, 2016, 146(10):1980-1990.
[13] BOHORA A A, KOKATE S R, KHEDKAR S, et al.Antimicrobial activity of probiotics against endodontic pathogens:A preliminary study[J].Indian Journal of Medical Microbiology, 2019, 37(1):5-11.
[14] ALIZADEH BEHBAHANI B, NOSHAD M, FALAH F.Inhibition of Escherichia coli adhesion to human intestinal Caco-2 cells by probiotic candidate Lactobacillus plantarum strain L15[J].Microbial Pathogenesis, 2019, 136:103677.
[15] SINGH T P, KAUR G, KAPILA S, et al.Antagonistic activity of Lactobacillus reuteri strains on the adhesion characteristics of selected pathogens[J].Frontiers in Microbiology, 2017, 8:486.
[16] 王鹏, 刚梦萱, 张臣臣, 等.母乳源乳酸菌的低聚糖利用特性研究[J].食品与发酵工业, 2022, 48(11):101-106.
WANG P, GANG M X, ZHANG C C, et al.Oligosaccharide utilization characteristics of lactic acid bacteria from breast milk[J].Food and Fermentation Industries, 2022, 48(11):101-106.
[17] COPPA G V, BRUNI S, ZAMPINI L, et al. Oligosaccharides of human milk inhibit the adhesion of listeria monocytogenes to Caco-2 cells[J].The Italian Journal of Pediatrics, 2003, 29(1):61-68.
[18] ELO S, SAXELIN M, SALMINEN S. Attachment of Lactobacillus casei strain GG to human colon carcinoma cell line Caco-2:Comparison with other dairy strains Lett[J].Letters in Applied Microbiology, 1991, 13(3):154-156.
[19] CHAUVIERE G, COCONNIER M H, KERNEIS S, et al.Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells[J].Journal of General Microbiology, 1992, 138(8):1689-1696.
[20] BERNET M F, BRASSART D, NEESER J R, et al.Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions[J].Applied and Environmental Microbiology, 1993,59(12):4121-4128.
[21] BEACHEY E H.Bacterial adherence:Adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces[J].The Journal of Infectious Diseases, 1981, 143(3):325-345.
[22] GRIGORYAN S, BAZUKYAN I, TRCHOUNIAN A.Aggregation and adhesion activity of lactobacilli isolated from fermented products in vitro and in vivo:A potential probiotic strain[J].Probiotics and Antimicrobial Proteins, 2018, 10(2):269-276.
[23] ENDO H, TAMURA K, FUKASAWA T, et al.Comparison of fructooligosaccharide utilization by Lactobacillus and Bacteroides species[J].Bioscience, Biotechnology, and Biochemistry, 2012, 76(1):176-179.
[24] FACINELLI B, MARINI E, MAGI G, et al.Breast milk oligosaccharides:Effects of 2′-fucosyllactose and 6′-sialyllactose on the adhesion of Escherichia coli and Salmonella fyris to Caco-2 cells[J].The Journal of Maternal-Fetal and Neonatal Medicine, 2019, 32(17):2950-2952.
[25] CILIEBORG M S, SANGILD P T, JENSEN M L, et al.α1,2-Fucosyllactose does not improve intestinal function or prevent Escherichia coli F18 diarrhea in newborn pigs[J].Journal of Pediatric Gastroenterology and Nutrition, 2017, 64(2):310-318.
[26] JANKOWSKA A, LAUBITZ D, ANTUSHEVICH H, et al.Competition of Lactobacillus paracasei with Salmonella enterica for adhesion to Caco-2 cells[J].Journal of Biomedicine and Biotechnology, 2008, 2008:357964.
[27] JAYASHREE S, KARTHIKEYAN R, NITHYALAKSHMI S, et al.Anti-adhesion property of the potential probiotic strain Lactobacillus fermentum 8711 against methicillin-resistant Staphylococcus aureus (MRSA)[J].Frontiers in Microbiology, 2018, 9:411.
[28] COCONNIER M H, BERNET M F, KERNÉIS S, et al.Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion[J].FEMS Microbiology Letters, 1993, 110(3):299-305.
